Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
Saved in:
| Title: | Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors. |
|---|---|
| Authors: | Prakoso, Emilia1, Strasser, Simone I.1, Koorey, David J.1, Verran, Deborah1, McCaughan, Geoffrey W.1 g.mccaughan@centenary.usyd.edu.au |
| Source: | Clinical Transplantation. May/Jun2006, Vol. 20 Issue 3, p369-373. 5p. 2 Charts. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
